Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
150.40    -2.20 (-1.44%)
Bid:
150.90
Ask:
151.10
Spread: 0.20 (0.133%)
Market Cap: £1.11b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Rule 8.3- Grainger PLC

5 Aug 2008 15:20

RNS Number : 7023A
BlackRock Group
05 August 2008
 



FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

BlackRock Group

Company dealt in

Grainger Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

GBP 0.05 ordinary

Date of dealing

4th August 2008 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

3,426,551

2.67%

(2) Derivatives (other than options)

305,912

0.23%

(3) Options and agreements to purchase/sell

Total

3,732,463

2.91%

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security: 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale 

Number of securities

Price per unit (Note 5)

Purchase

37,927

GBP 2.00

 (b) Derivatives transactions (other than options)

 

Product name, e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

CFD

Long

12,073

GBP 2.003

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name ,e.g. call option 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5) 

 

 (ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None……………………………………………………………………

……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

 

 

Date of disclosure

5th August 2008

Contact name

Kai Chew

Telephone number

020 7743 2602

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETMGGGRDKLGRZM
Date   Source Headline
1st Dec 201711:21 amRNSDirector Declaration
30th Nov 20177:00 amRNSFull Year Results
24th Nov 20177:00 amRNSAcquisition
23rd Nov 201710:08 amRNSDirector Declaration
23rd Nov 20177:00 amRNSAcquisition
13th Nov 201712:18 pmRNSTotal Voting Rights
7th Nov 20173:49 pmRNSDirector/PDMR Shareholding
2nd Nov 201712:18 pmRNSHolding(s) in Company
27th Oct 20177:00 amRNSNotice of Preliminary Results & 2018 Calendar
16th Oct 201712:46 pmRNSDirectorate Change
10th Oct 20172:22 pmRNSTotal Voting Rights
6th Oct 201710:52 amRNSDirector/PDMR Shareholding
3rd Oct 20173:11 pmRNSBlock listing Interim Review
3rd Oct 20173:10 pmRNSBlock listing Interim Review
27th Sep 20177:00 amRNSPre-Close Statement & Capital Markets Day
20th Sep 201710:31 amRNSDirector/PDMR Shareholding
13th Sep 20172:09 pmRNSDirector/PDMR Shareholding
12th Sep 201711:32 amRNSTotal Voting Rights
30th Aug 20179:30 amRNSDirectorate Change
29th Aug 20177:00 amRNS£80m build-to-rent scheme in Salford
8th Aug 201711:24 amRNSTotal Voting Rights
7th Aug 20173:48 pmRNSDirector/PDMR Shareholding
2nd Aug 20172:33 pmRNSHolding(s) in Company
1st Aug 20177:00 amRNS£30.5M PRS Acquisition
24th Jul 20177:00 amRNSAcquisition of PRS build-to-rent development
18th Jul 20173:52 pmRNSHolding(s) in Company
5th Jul 20179:33 amRNSDirector/PDMR Shareholding
5th Jul 20179:31 amRNSTotal Voting Rights
4th Jul 20174:08 pmRNSHolding(s) in Company
30th Jun 20171:55 pmRNSDirector Declaration
8th Jun 201711:28 amRNSDirector/PDMR Shareholding
6th Jun 20171:55 pmRNSTotal Voting Rights
6th Jun 201711:44 amRNSDirector/PDMR Shareholding
2nd Jun 20174:11 pmRNSHolding(s) in Company
24th May 201711:40 amRNSHolding(s) in Company
19th May 20177:00 amRNSHalf Year Results
8th May 20172:59 pmRNSDirector/PDMR Shareholding
5th May 20172:18 pmRNSHolding(s) in Company
4th May 20173:02 pmRNSTotal Voting Rights
20th Apr 201711:22 amRNSHolding(s) in Company
6th Apr 20174:22 pmRNSHolding(s) in Company
6th Apr 201711:29 amRNSTotal Voting Rights
6th Apr 201710:39 amRNSDirector/PDMR Shareholding
3rd Apr 20174:23 pmRNSBlock listing Interim Review
3rd Apr 20174:20 pmRNSBlock listing Interim Review
9th Mar 20174:00 pmRNSTotal Voting Rights
8th Mar 201711:07 amRNSDirector/PDMR Shareholding
7th Mar 20174:00 pmRNSDirector/PDMR Shareholding
7th Mar 20173:56 pmRNSHolding(s) in Company
6th Mar 201711:33 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.